Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules.

Andersen TK, Huszthy PC, Gopalakrishnan RP, Jacobsen JT, Fauskanger M, Tveita AA, Grødeland G, Bogen B.

NPJ Vaccines. 2019 Feb 11;4:9. doi: 10.1038/s41541-019-0101-0. eCollection 2019.

2.

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

Mooij P, Grødeland G, Koopman G, Andersen TK, Mortier D, Nieuwenhuis IG, Verschoor EJ, Fagrouch Z, Bogers WM, Bogen B.

Vaccine. 2019 Feb 4;37(6):817-826. doi: 10.1016/j.vaccine.2018.12.049. Epub 2019 Jan 9.

3.

Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.

Anderson AM, Baranowska-Hustad M, Braathen R, Grodeland G, Bogen B.

J Immunol. 2018 Mar 15;200(6):2057-2066. doi: 10.4049/jimmunol.1701088. Epub 2018 Feb 2.

4.

The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules.

Braathen R, Spång HCL, Lindeberg MM, Fossum E, Grødeland G, Fredriksen AB, Bogen B.

Immunohorizons. 2018 Jan 18;2(1):38-53. doi: 10.4049/immunohorizons.1700038.

PMID:
31022690
5.

A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.

Andersen TK, Zhou F, Cox R, Bogen B, Grødeland G.

J Virol. 2017 Nov 14;91(23). pii: e01340-17. doi: 10.1128/JVI.01340-17. Print 2017 Dec 1.

6.

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Grodeland G, Fredriksen AB, Løset GÅ, Vikse E, Fugger L, Bogen B.

J Immunol. 2016 Nov 1;197(9):3575-3585. Epub 2016 Sep 26.

7.

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.

Lambert L, Kinnear E, McDonald JU, Grodeland G, Bogen B, Stubsrud E, Lindeberg MM, Fredriksen AB, Tregoning JS.

Front Immunol. 2016 Aug 23;7:321. doi: 10.3389/fimmu.2016.00321. eCollection 2016.

8.

Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.

Baranowska M, Hauge AG, Hoornaert C, Bogen B, Grødeland G.

Vaccine. 2015 Dec 8;33(49):6988-96. doi: 10.1016/j.vaccine.2015.08.094. Epub 2015 Sep 19.

9.

Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines.

Grødeland G, Fossum E, Bogen B.

Front Immunol. 2015 Jul 20;6:367. doi: 10.3389/fimmu.2015.00367. eCollection 2015. Review.

10.

Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.

Grødeland G, Bogen B.

Expert Rev Vaccines. 2015 Jun;14(6):805-14. doi: 10.1586/14760584.2015.1029919. Epub 2015 Mar 27. Review.

PMID:
25818107
11.

Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.

Fossum E, Grødeland G, Terhorst D, Tveita AA, Vikse E, Mjaaland S, Henri S, Malissen B, Bogen B.

Eur J Immunol. 2015 Feb;45(2):624-35. doi: 10.1002/eji.201445080. Epub 2014 Dec 28.

12.

The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype.

Grødeland G, Mjaaland S, Tunheim G, Fredriksen AB, Bogen B.

PLoS One. 2013 Nov 11;8(11):e80008. doi: 10.1371/journal.pone.0080008. eCollection 2013.

13.

DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

Grodeland G, Mjaaland S, Roux KH, Fredriksen AB, Bogen B.

J Immunol. 2013 Sep 15;191(6):3221-31. doi: 10.4049/jimmunol.1300504. Epub 2013 Aug 16.

14.

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines.

Ruffini PA, Grødeland G, Fredriksen AB, Bogen B.

Vaccine. 2010 Dec 16;29(2):191-9. doi: 10.1016/j.vaccine.2010.10.057. Epub 2010 Nov 4.

PMID:
21055498
15.

Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro.

Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD.

Chronobiol Int. 2009 Feb;26(2):242-57. doi: 10.1080/07420520902766025.

PMID:
19212839

Supplemental Content

Loading ...
Support Center